Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

SLAMF7 Antikörper (AA 249-335)

SLAMF7 Reaktivität: Human IHC (f) Wirt: Maus Monoclonal unconjugated
Produktnummer ABIN7126855
  • Target Alle SLAMF7 Antikörper anzeigen
    SLAMF7 (SLAM Family Member 7 (SLAMF7))
    Bindungsspezifität
    • 16
    • 7
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    AA 249-335
    Reaktivität
    • 44
    • 23
    • 3
    Human
    Wirt
    • 31
    • 14
    • 3
    Maus
    Klonalität
    • 34
    • 14
    Monoklonal
    Konjugat
    • 23
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser SLAMF7 Antikörper ist unkonjugiert
    Applikation
    • 37
    • 22
    • 18
    • 9
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
    Spezifität
    CS1, also known as novel Ly9, SLAMF7, 19A24 or CRACC, is a homophilic cell surface receptor. It is a member of the SLAM (signaling lymphocytic activation molecule) family of receptors expressed on natural killer (NK) cells, T cells and stimulated B cells. CS1 contains immunoreceptor tyrosine-based switch motifs in its cytoplasmic domain but, unlike other SLAM receptors, it does not recruit SAP (SLAM-associated protein). In humans, CS1 activates NK cells through an EAT-2-mediated pathway that is SAP-independent. CS1 recruits and associates with EAT-2, a protein closely related to SAP. EAT-2 induces phosphorylation of CS1 which then, upon ligand binding, activates downstream cytotoxicity effectors PLC and PI 3K. In mice, the EAT-2 association with CS1 has an inhibitory effect on the activation of NK cells.
    Kreuzreaktivität (Details)
    Human.
    Aufreinigung
    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.
    Immunogen
    Recombinant fragment of human SLAMF7 protein (around aa 249-335) (exact sequence is proprietary)
    Isotyp
    IgG1
    Top Product
    Discover our top product SLAMF7 Primärantikörper
  • Applikationshinweise

    Known_Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: Human tonsil tissue.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    1.0 mg/mL
    Buffer
    Prepared in 10 mM PBS, WITHOUT BSA and Azide.
    Konservierungsmittel
    Azide free
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.
    Haltbarkeit
    24 months
  • Target
    SLAMF7 (SLAM Family Member 7 (SLAMF7))
    Andere Bezeichnung
    SLAMF7 (SLAMF7 Produkte)
    Synonyme
    RGD1560190 antikoerper, SLAMF7 antikoerper, slaf7 antikoerper, 19A antikoerper, CD319 antikoerper, CRACC antikoerper, CS1 antikoerper, 19A24 antikoerper, 4930560D03Rik antikoerper, SLAM family member 7 antikoerper, Slamf7 antikoerper, SLAMF7 antikoerper, slaf7 antikoerper
    Hintergrund
    19A, 19A24 protein, CD2 like receptor activating cytotoxic cells, CD2 subset 1, CRACC, CS1, Membrane protein FOAP 12, Novel LY9 (lymphocyte antigen 9) like protein, Protein 19A, SLAM family member 7,SLAMF7 / CS1 / CD319
    Cellular localisation: Cell surface
    Molekulargewicht
    37kDa
    Gen-ID
    57823, 517265
    UniProt
    Q9NQ25
Sie sind hier: